RKDA

Arcadia Biosciences Inc

Add to Watchlist

Advanced Chart

4.280

+0.09(2.148%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

4.470

Open

4.190

VWAP

4.36

Vol

12.93K

Mkt Cap

5.85M

Low

4.075

Amount

56.30K

EV/EBITDA(TTM)

Total Shares

1.36M

2.57M

EV/OCF(TTM)

P/S(TTM)

1.08

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

1.40M

+15.13%

2.20M

+43.14%

1.60M

+22.51%

Estimates Revision

The market is revising No Change the revenue expectations for Arcadia Biosciences, Inc. (RKDA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 23.88%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+23.88%

In Past 3 Month

1 Analyst Rating

180.37% Upside

Wall Street analysts forecast RKDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RKDA is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

180.37% Upside

Current: 4.280

Low

12.00

Averages

12.00

High

12.00

180.37% Upside

Current: 4.280

Low

12.00

Averages

12.00

High

12.00

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

2024-08-21

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

2024-08-21

Reiterates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Arcadia Biosciences Inc (RKDA.O) is -1.61, compared to its 5-year average forward P/E of -1.79. For a more detailed relative valuation and DCF analysis to assess Arcadia Biosciences Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.79

Current PE

-1.61

Overvalued PE

-0.58

Undervalued PE

-2.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.08

Current EV/EBITDA

-0.98

Overvalued EV/EBITDA

1.19

Undervalued EV/EBITDA

-1.03

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.86

Current PS

0.87

Overvalued PS

3.68

Undervalued PS

0.04